Oligodendroglioma: Clinical Trials

23 trials for Oligodendroglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 3 active not recruiting, 3 recruiting. 23 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 323Completed 7, Unknown 4, Active not recruiting 3, Recruiting 3, Terminated 3, Withdrawn 2, Not yet recruiting 1
Phase 22Completed 1, Withdrawn 1

Follow Oligodendroglioma: new trials by email Literature Review of Oligodendroglioma trials Research Report on Oligodendroglioma

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma
Safusidenib, Placebo - Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation, Astrocytoma IDH Mutant Grade 2
Phase 3Not yet recruitingNuvation Bio Inc.1402027-03-012026-07-17
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
safusidenib, Placebo - Glioma, Astrocytoma, Grade IV
Phase 3RecruitingNuvation Bio Inc.3652023-06-052026-10-19
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
PCV chemotherapy, Radiotherapy and PCV chemotherapy - Oligodendroglioma, Low-grade Oligodendroglioma
Phase 3RecruitingHospices Civils de Lyon2802021-12-072026-01-29
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
CETEG, PCV, RT - Oligodendroglioma
Phase 3RecruitingUniversity Hospital Heidelberg4062021-04-072026-02-03
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
Extended Release Flucytosine, NovoTTF-100A Device, Quality-of-Life Assessment - Anaplastic Astrocytoma, Glioblastoma
Phase 2 / Phase 3WithdrawnNRG Oncology2020-01-312026-05-07
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Carmustine, tumor resection surgery - Anaplastic Astrocytoma, Anaplastic Oligodendroglioma
Phase 3UnknownShandong Lanjin Pharmaceuticals Co.,Ltd2362012-08-012012-08-03
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
Radiotherapy, Temozolomide - Astrocytoma, Oligodendroglioma
Phase 3UnknownSun Yat-sen University2902012-07-012020-05-28
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
temozolomide, 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy - Brain and Central Nervous System Tumors, Neurotoxicity
Phase 3Active not recruitingEastern Cooperative Oncology Group5402009-11-172026-10-05
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
concomitant temozolomide (TMZ), radiotherapy, procarbazine - Brain and Central Nervous System Tumors
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology3052009-09-012026-01-22
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease
Phase 3CompletedWake Forest University Health Sciences1982008-02-012021-10-20
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
temozolomide, DNA methylation analysis, laboratory biomarker analysis - Brain and Central Nervous System Tumors
Phase 3Active not recruitingEuropean Organisation for Research and Treatment of Cancer - EORTC7512007-12-012023-09-11
Treatment Strategy for Low-grade Gliomas
Radiation therapy, Temozolomide - Astrocytomas, Oligodendrogliomas
Phase 3TerminatedSun Yat-sen University5002007-12-012014-08-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
temozolomide, radiation therapy - Brain and Central Nervous System Tumors
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC7092005-07-012016-10-12
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
carboplatin, cisplatin, cyclophosphamide - Brain and Central Nervous System Tumors
Phase 3UnknownChildren's Hospital Los Angeles1202004-03-012013-12-18
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
methylphenidate hydrochloride, quality-of-life assessment, radiation therapy - Brain and Central Nervous System Tumors, Cognitive/Functional Effects
Phase 3TerminatedWake Forest University Health Sciences2002-04-012021-09-09
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Temozolomide, Focal radiotherapy - Anaplastic Astrocytoma, Oligodendroglioma
Phase 3CompletedNeuro-Oncology Working Group of the German Cancer Society3181999-06-012008-07-17
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
lomustine, procarbazine hydrochloride, vincristine sulfate - Brain and Central Nervous System Tumors
Phase 2 / Phase 3CompletedRadiation Therapy Oncology Group3701998-10-012024-07-09
Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
carboplatin, vincristine sulfate, conventional surgery - Brain and Central Nervous System Tumors
Phase 3UnknownSociete Internationale d'Oncologie Pediatrique2001997-01-012013-12-04

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Astrocytoma (18)  ·  Central Nervous System Neoplasms (11)  ·  Glioma (10)  ·  Glioblastoma (8)  ·  Brain Neoplasms (6)  ·  Choroid Plexus Neoplasms (4)  ·  Gliosarcoma (4)  ·  Ependymoma (3)  ·  Glioma, Subependymal (3)  ·  Medulloblastoma (3)  ·  Meningioma (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Chondrosarcoma (2)  ·  Craniopharyngioma (2)

Broader conditions

Neoplasms by Histologic Type (23)  ·  Neoplasms, Germ Cell and Embryonal (23)  ·  Neoplasms, Glandular and Epithelial (23)  ·  Neoplasms, Nerve Tissue (23)  ·  Neuroectodermal Tumors (23)  ·  Neoplasms, Neuroepithelial (22)  ·  Neoplasms (21)  ·  Neoplasms by Site (14)  ·  Nervous System Diseases (14)  ·  Nervous System Neoplasms (14)  ·  Glioma (13)  ·  Brain Diseases (8)  ·  Central Nervous System Diseases (8)  ·  Cerebral Ventricle Neoplasms (4)  ·  Neoplasms, Vascular Tissue (4)

Interventions

Radiotherapy (14)  ·  Temozolomide (9)  ·  Vincristine (7)  ·  Procarbazine (6)  ·  Lomustine (5)  ·  Carboplatin (2)  ·  Carmustine (1)  ·  Chemotherapy, Adjuvant (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Cyproheptadine (1)  ·  DNA (1)  ·  DNA Methylation (1)  ·  Donepezil (1)  ·  Etoposide (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (3)  ·  Nuvation Bio Inc. (2)  ·  Radiation Therapy Oncology Group (2)  ·  Sun Yat-sen University (2)  ·  Wake Forest University Health Sciences (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Children's Hospital Los Angeles (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Hospices Civils de Lyon (1)  ·  INSYS Therapeutics Inc (1)  ·  M.D. Anderson Cancer Center (1)  ·  NRG Oncology (1)  ·  Neuro-Oncology Working Group of the German Cancer Society (1)  ·  Shandong Lanjin Pharmaceuticals Co.,Ltd (1)  ·  Societe Internationale d'Oncologie Pediatrique (1)

Countries

United States (10)  ·  Germany (6)  ·  France (5)  ·  Australia (4)  ·  Belgium (4)  ·  Canada (4)  ·  China (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Switzerland (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Hungary (2)  ·  Israel (2)  ·  New Zealand (2)

Top investigators

Edward G. Shaw, MD (2)  ·  Anna Nowak, MD (1)  ·  Brigitta Baumert, MD, PhD (1)  ·  David A. Walker (1)  ·  David Schiff, MD (1)  ·  Geoffrey R. Barger, MD (1)  ·  Girish Dhall, MD (1)  ·  J. Gregory Cairncross, MD (1)  ·  Jan C. Buckner, MD (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  Jonathan L. Finlay, MB, ChB (1)  ·  Karen L. Fink, MD, PhD (1)  ·  Kelley Haley, RN, BSN (1)  ·  Kurt A. Jaeckle, MD (1)  ·  Kurt Jaeckle, MD (1)

Results publications

PMID 35731991, PMID 11586105, PMID 16782910, PMID 16782911, PMID 17549014, PMID 18089866, PMID 18089867, PMID 18371182, PMID 18976072, PMID 19224764, PMID 19783377, PMID 19901104, PMID 20160062, PMID 20820870, PMID 21246521, PMID 21914791, PMID 22480131, PMID 22851558, PMID 23071237, PMID 23071247, PMID 23269986, PMID 24419119, PMID 27020837, PMID 27050206, PMID 27370396, PMID 27686943, PMID 27686946, PMID 28801186, PMID 29393183, PMID 29571083, PMID 31386061, PMID 32706640, PMID 34000245, PMID 35275197, PMID 35692047, PMID 41449147

NIH funding

2004 (1), 2018 (1), P30CA016672 (1), U10CA081851 (1), U10CA081920 (1), U10CA180868 (1)